Description
Trade name:
Broncho-Vaxom for children
Compound:
Each capsule contains:
standardized lyophilisate of bacterial lysates (Haemophilus influenzae, Streptococcus pneumoniae, Streptococcus viridans, Streptococcus pyogenes, Klebsiella pneumoniae, Klebsiella ozaenae, Staphylococcus aureus, Moraxella catarrhalis) 3.5 mg
Excipients: anhydrous propyl gallate (E310); sodium glutamate; mannitol; pregelatinized starch; magnesium stearate; mannitol capsule shell: indigo carmine dye (indigotine) (E132); titanium dioxide (E171), gelatin.
Properties:
An immunostimulating drug of bacterial origin. Causes an immune response of the mucous membrane of the digestive tract. The effect is especially evident in the Peyer’s patches (PP) of the small intestine. Antigen-presenting cells (APC) in the PP are activated by the drug and subsequently stimulate cells responsible for specific immunity. When using the drug, an increase in the number of circulating B-lymphocytes is observed.
Following stimulation of B lymphocytes, an increase in the production of polyclonal antibodies is observed, especially serum IgG and IgA secreted by the respiratory mucosa and saliva.
These antibodies are the first line of defense against a wide range of infectious agents (viruses and bacteria).
The drug has a powerful stimulating effect on most types of leukocytes, as evidenced by an increase in the number of myeloid and lymphoid cells, as well as a selective increase in the expression of receptors on their surface. Taken together, these data confirm that the drug triggers biological reactions that enhance the body’s immune defense against infection.
Clinically, Broncho-Vaxom for children reduces the frequency of acute respiratory tract infections, shortens their duration, reduces the likelihood of exacerbations of chronic bronchitis, and increases the body’s resistance to respiratory infections. At the same time, the need for other drugs, especially antibiotics, is reduced.
Indications:
The drug is used in children from 6 months to 12 years of age for the following indications:
– prevention of recurrent respiratory tract infections and exacerbations of chronic bronchitis;
-complex treatment of acute respiratory tract infections.
Method of administration and dosage:
Inside.
Treatment: 1 capsule of Broncho-Vaxom for children daily in the morning on an empty stomach until symptoms disappear, but not less than 10 days. If antibiotic therapy is necessary, Broncho-Vaxom for children should be taken in combination with an antibiotic from the beginning of treatment.
The duration of treatment or the appointment of a repeated course of therapy should be determined by the physician, based on the patient’s health condition.
Prevention of exacerbations and maintenance therapy: 1 capsule of Broncho-Vaxom for children daily in the morning on an empty stomach. The course includes 3 cycles, each of which consists of daily intake of 1 capsule for 10 days, the interval between cycles is 20 days.
If the capsule is difficult to swallow, it should be opened and the contents mixed with a drink (including fruit juice, milk).
Contraindications:
Hypersensitivity to the components of the drug.
Precautions:
Broncho-Vaxom for children should not be used in children under 6 months of age.
To avoid overdose, do not use the drug in capsule form intended for adults (Broncho-Vaxom adult, capsules, 7 mg).
The components of the drug may cause hypersensitivity reactions.
In case of persistent gastrointestinal disorders, skin reactions, respiratory disorders or other symptoms of drug intolerance, treatment should be discontinued, since these symptoms are manifestations of allergic reactions.
Side effects:
From the gastrointestinal tract: often – diarrhea, abdominal pain; unknown – vomiting, nausea.
From the nervous system: unknown – headache.
From the respiratory system, chest organs and mediastinum: often – cough.
From the skin and subcutaneous tissue: often – rash; unknown – urticaria, Quincke’s edema.
General disorders and administration site conditions: unknown – fever, fatigue.
From the immune system: uncommon – hypersensitivity (erythematous rash, generalized rash, erythema, eyelid edema, facial edema, peripheral edema, facial swelling, itching, generalized itching, dyspnea).
Storage method:
Store at temperatures not exceeding 30 degrees.
